-
Building on ‘Contemporary Practice and Considerations for Real-World Data (RWD) Source Identification and Feasibility Assessment’: Mapping Feasibility Criteria Across 46 Real-World Evidence (RWE) Guidelines
Mar 10, 2025, 14:00 PM -
Evaluating the Effects of the COVID-19 Pandemic on ICU Mortality and Sedation Charges in Mechanically Ventilated Patients
Mar 10, 2025, 14:00 PM -
Amelioration of Indirect Costs Following COVID-19 Infection in High-Risk US Patients Treated With Nirmatrelvir-Ritonavir
Mar 10, 2025, 14:00 PM -
Sex-Stratified Differences in Cardiac Interventions, Complications and Outcomes in the Netherlands Between 2018 and 2023
Mar 10, 2025, 14:00 PM -
Three Different Methods to Estimate a Rare Disease (RD) Prevalence in a Country with a Limited Dataset: Which One Fits?
Mar 10, 2025, 14:00 PM -
Superior Performance of Generative AI After Application of Mixture-of-Agents LLMs in Outcomes Research
Mar 10, 2025, 14:00 PM -
Descriptive Analysis Of Patients With Psoriasis (PSO) Using Biologics Vs. Non-biologics
Mar 10, 2025, 14:00 PM -
Development of a Novel Approach to Improve Binary Classification Prediction Tasks When Encountering Time-To-Event Data: Performance Comparison of Three Alternative Approaches To Predict Stimulant Use Disorder Among Persons Authorized To Purchase...
Mar 10, 2025, 14:00 PM -
Evaluating Pain Scores and Detecting NSCLC Using Named Entity Recognition and Agentic AI in Clinical Texts
Mar 10, 2025, 14:00 PM -
The Economic Burden of Narcolepsy in the United States: Matched Analysis of National Health and Wellness Survey Data
Mar 10, 2025, 14:00 PM -
Examining Burden of Disease and Access to Care in Adults with X-Linked Hypophosphatemia in Brazil
Mar 10, 2025, 14:00 PM -
Formulary Inclusion for Oncologic Indications: Comparing FDA-Approved Indications and Off-Label Compendia Support
Mar 10, 2025, 14:00 PM -
A Descriptive Analysis of Demographic, Co-Morbid and Prescribing Data from the UK CPRD in People with Type 2 Diabetes and Cardiovascular Conditions
Mar 10, 2025, 14:00 PM -
Treatment Patterns, Clinical Outcomes, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Metastatic Gastric/Gastroesophageal Junction Cancer in Medicare Beneficiaries
Mar 10, 2025, 14:00 PM -
Recurrent Patient-Reported Outcome (PRO)-Based Symptomatic Deterioration Predicts Survival and Disease Progression in Patients With Resectable Non-Small Cell Lung Cancer (NSCLC): Post-Hoc Analysis of RATIONALE-315
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs Among Adolescent Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): A US Administrative Claims Database Study
Mar 10, 2025, 14:00 PM -
Absenteeism and Presenteeism Associated With Chronic Conditions in a Canadian Working Population
Mar 10, 2025, 14:00 PM -
The Importance of Specifying the Estimand in Meta-Analyses in the Presence of Treatment Switching
Mar 10, 2025, 14:00 PM -
Cost-Minimization: Consequences of Using the Lowest Cost Comparator Over the Weighted Average Cost (WAC)
Mar 10, 2025, 14:00 PM -
Cost-Benefit Evaluation of Containers in the Central Sterile Services Department (CSSD)
Mar 10, 2025, 14:00 PM
